The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
- PMID: 1535557
- DOI: 10.1016/0092-8674(92)90644-r
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Abstract
A cellular phosphoprotein with an apparent molecular mass of 90 kd (p90) that forms a complex with both mutant and wild-type p53 protein has been characterized, purified, and identified. The protein was identified as a product of the murine double minute 2 gene (mdm-2). The mdm-2 gene enhances the tumorigenic potential of cells when it is overexpressed and encodes a putative transcription factor. To determine if mdm-2 could modulate p53 transactivation, a p53-responsive element from the muscle creatine kinase gene was employed. A wild-type p53-expressing plasmid enhanced the expression of the p53-responsive element when cotransfected into cells that contain no endogenous p53. When a cosmid expressing mdm-2 was transfected with this p53-expressing plasmid, the transactivation of the p53-responsive element was inhibited. Thus, a product of the mdm-2 oncogene forms a tight complex with the p53 protein, and the mdm-2 oncogene can inhibit p53-mediated transactivation.
Similar articles
-
Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.Mol Med. 1995 Jan;1(2):142-52. Mol Med. 1995. PMID: 8529093 Free PMC article.
-
Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.Oncogene. 1993 Sep;8(9):2353-60. Oncogene. 1993. PMID: 7689721
-
Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes Dev. 1994 May 15;8(10):1235-46. doi: 10.1101/gad.8.10.1235. Genes Dev. 1994. PMID: 7926727
-
Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.Oncogene. 2001 Jan 18;20(3):395-8. doi: 10.1038/sj.onc.1204055. Oncogene. 2001. PMID: 11313969 Review.
-
The regulation of p53-mediated transcription and the roles of hTAFII31 and mdm-2.Harvey Lect. 1994-1995;90:81-93. Harvey Lect. 1994. PMID: 8803320 Review. No abstract available.
Cited by
-
MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.Oncogene. 2013 Apr 25;32(17):2169-78. doi: 10.1038/onc.2012.238. Epub 2012 Jun 18. Oncogene. 2013. PMID: 22710720 Free PMC article.
-
125I Seed Promotes Apoptosis in Non-small Lung Cancer Cells via the p38 MAPK-MDM2-p53 Signaling Pathway.Front Oncol. 2021 Apr 21;11:582511. doi: 10.3389/fonc.2021.582511. eCollection 2021. Front Oncol. 2021. PMID: 33968713 Free PMC article.
-
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.Cell Rep. 2016 Sep 6;16(10):2618-2629. doi: 10.1016/j.celrep.2016.08.014. Epub 2016 Aug 25. Cell Rep. 2016. PMID: 27568562 Free PMC article.
-
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.Oncogene. 2016 Feb 25;35(8):977-89. doi: 10.1038/onc.2015.147. Epub 2015 May 11. Oncogene. 2016. PMID: 25961931
-
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27. Blood. 2012. PMID: 23018641 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous